Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study

BACKGROUND: This study aimed to identify the effect of histamine-2 receptor antagonist (H2RA) and proton pump inhibitor (PPI) use on the positivity rate and clinical outcomes of coronavirus disease 2019 (COVID-19). METHODS: We performed a nationwide cohort study with propensity score matching using...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bokyung, Jung, Jin-Hyung, Han, Kyungdo, Kang, Seungkyung, Lee, Eunwoo, Chung, Hyunsoo, Kim, Sang Gyun, Cho, Soo-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070049/
https://www.ncbi.nlm.nih.gov/pubmed/37012686
http://dx.doi.org/10.3346/jkms.2023.38.e99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070049/
https://www.ncbi.nlm.nih.gov/pubmed/37012686
http://dx.doi.org/10.3346/jkms.2023.38.e99

Ejemplares similares